Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company. Cortex is a privately held medical technology ...

Avation Medical, an innovative neuromodulation and digital health company on a mission to make non-invasive, physiologic, closed-loop neuromodulation accessible to patients across a variety of ...

The Paradise Ultrasound Renal Denervation (uRDN) system becomes the first and only ultrasound-based renal denervation (RDN) therapy to be granted a distinct category and device code for incremental ...

Immorta Bio, a scientific longevity company focused on “Treating Diseases of Aging and Treating Aging as Disease™,” announced today successful treatment of aggressive breast cancer in animal models ...

The MedTech industry continues to thrive and innovate. According to Markets and Market’s “The Global MedTech Industry Outlook 2024” report, the MedTech market is expected to grow 4% in 2024 to $668.2B ...

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring DELFI Diagnostics, Inc., developer of accessible blood-based ...

Exactech, a global medical technology leader, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Truliant® Porous Tibial Tray, a 3D tibial knee ...

Complementary Acquisition Expands Kewaunee’s Product Offerings and Market Reach Carl Marks Securities, an affiliate of middle market investment bank Carl Marks Advisors, today announced that it has ...

GT Metabolic Solutions Inc., the global leader in magnetic compression anastomosis surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared GT Metabolic’s MagDI™ System for ...

Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, announced today the appointment of seasoned medical device executive Jay Hallinan as ...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the second closing of its Series A ...

Edwards Lifesciences today announced results from the EARLY TAVR Trial, the first randomized, controlled trial designed to study the best strategy for treating asymptomatic severe aortic stenosis (AS) ...